nad has been researched along with kp372-1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Chen, X; Cheng, F; Hu, H; Hu, Q; Huang, X; Loscalzo, J; Qian, X; Su, N; Tang, Y; Wang, A; Wang, X; Yang, K; Yang, Y; Yi, J; Zhao, Y; Zhou, HM; Zhu, L; Zhu, Q; Zou, Y | 1 |
1 other study(ies) available for nad and kp372-1
Article | Year |
---|---|
SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 4 or More Rings; Humans; Mice, Nude; NAD; NAD(P)H Dehydrogenase (Quinone); Neoplasms; Oxidation-Reduction; Oxidative Stress; Pentose Phosphate Pathway; Tetrazoles | 2015 |